abstract |
A pharmaceutical dosage system comprising: (a) from about to about 40 mg of one or more of (i) doxylamine and (ii) a pharmaceutically acceptable salt thereof; (b) from about to about 80 mg of one or more of (i) a pyridoxine compound of formula II, wherein R 1 is a hydroxyl or phosphate group; and R2 is CH2OH, CHO, or CH2NH2; (ii) a pharmaceutically acceptable ester of (i); and (iii) a pharmaceutically acceptable salt of any of (i) - (ii); and (c) from about 20 to about 100 mg of one or more riboflavin, riboflavin-5-phosphate, flavin adenine dinucleotide, or a pharmaceutically acceptable salt thereof. |